At present, several genetic risk factors for NAFLD have been identified, such as polymorphisms of patatin like phospholipase domain containing 3 (PNPLA3), transmembrane 6 superfamily member 2, and hydroxysteroid 17-beta dehydrogenase 13 (2). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.